Alexander KarpAlexander Karp earned $1B in 2024

In 2012, Dr. Mark N. Greene earned $411.53K in total compensation at Fair Isaac, primarily from $403.65K salary. Most recently sold 3,000 shares in Mar 2011. Led Fair Isaac as CEO for 4 years.

Compensation History

Annual executive compensation data for Dr. Mark N. Greene, including salary, bonuses, and stock awards.

Year

2012

Total Compensation

$411.53K

Salary

$403.65K

Bonus

$0.00

Other

$7.88K

Salary

$403.65K

Board Justification

The compensation philosophy emphasizes performance-based pay, aligning executive compensation with company performance and stockholder interests.

Bonus

$0.00

Board Justification

Dr. Greene did not receive a bonus for fiscal year 2012 as he was not eligible for a payout under the Management Incentive Plan due to his transition agreement.

Other Compensation

$7.88K

Board Justification

Other compensation includes benefits such as 401(k) match and life insurance premiums.

Restricted Stock

$0.000 N/A

Board Justification

No stock awards vested in 2012 as Dr. Greene's stock awards were not reported in the fiscal year 2012 summary compensation table.

Performance Metrics

The performance metrics for determining compensation included revenue and net income targets.

F

Dr. Mark N. Greene

Ex-CEO of Fair Isaac

Education

Ph.D. in Management Science

Field of Expertise

Business & Management

Sector of Economy

Technology

Born

January 1, 1954 - 71 years ago

CEO of Fair Isaac for

4 years 11 months (Feb 2007 - Jan 2012)

Previous Experience

CEO of Fair Isaac Corporation

Holdings

Track Dr. Mark N. Greene's stock holdings and portfolio value over time.

Total Stock Sold

$86.91K

FICO

$86.91K

3,000 FICO shares

What if they kept their stock?

If Dr. Mark N. Greene didn't sell their stock, today they would have:
Extra FICO3,000 shares worth $5.40M.
This is 6,108.25% and $5.31M more than what they got when they sold the stock.

Insider Trading

Dr. Mark N. Greene's recent stock transactions, purchases, and sales filed with the SEC.

Rivals

Compare Dr. Mark N. Greene with competitor CEOs and industry peers.